Recombinant Human LILRB2/CD85d/ILT4 Protein

來(lái)源: 發(fā)布時(shí)間:2024-04-15

Recombinant Biotinylated Human MSLN/Mesothelin Protein,hFc-Avi Tag分子別名(Synonyms)Mesothelin;CAK1;MSLN;MPFSMRP表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)BiotinylatedHumanMSLN/MesothelinProteinisexpressedfromHEK293withhFctagandAvitagattheC-Terminus.ItcontainsGlu296-Gly580.[Accession|Q13421-2]分子量大?。∕olecularWeight)TheproteinhasapredictedMWof61.1kDa.Duetoglycosylation,theproteinmigratesto70-80kDabasedonSDS-PAGEresult.(Endotoxin)Lessthan1EUperμgbytheLALmethod.純度(Purity)>95%asdeterminedbySDS-PAGEandHPLC.活性(Activity)ELISAData:ImmobilizedAnti-MSLNAntibody,hFcTagat1μg/ml(100μl/well)ontheplate.DoseresponsecurveforBiotinylatedHumanMSLN,hFcTagwiththeEC50of18.4ng/mldeterminedbyELISA.CX3CL1還通過(guò)募集巨噬細(xì)胞以及通過(guò)募集和介導(dǎo)破骨細(xì)胞前體的粘附而導(dǎo)致傷口愈合。Recombinant Human LILRB2/CD85d/ILT4 Protein,His-Avi Tag

Recombinant Human LILRB2/CD85d/ILT4 Protein,His-Avi Tag,標(biāo)準(zhǔn)物質(zhì)

Recombinant Biotinylated Human ENPP-3 Protein,His-Avi Tag性能參數(shù)分子別名(Synonyms)NPP3;E-NPP3;PD-Ibeta表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)BiotinylatedHumanENPP-3ProteinisexpressedfromHEK293withHistagandAvitagattheN-Terminus.ItcontainsLeu48-Ile875.[Accession|O14638]分子量大小(MolecularWeight)TheproteinhasapredictedMWof99.97kDa.Duetoglycosylation,theproteinmigratesto110-130kDabasedonSDS-PAGEresult.(Endotoxin)Lessthan1EUperμgbytheLALmethod.純度(Purity)>95%asdeterminedbySDS-PAGEandHPLC.制劑(Formulation)Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally8%trehaloseisaddedasprotectantbeforelyophilization.重構(gòu)方法(Reconstitution)Centrifugethetubebeforeopening.Reconstitutingtoaconcentrationmorethan100μg/mlisrecommended.Dissolvethelyophilizedproteinindistilledwater.儲(chǔ)存條件Theproductshouldbestoredat-25~-15℃for1yearfromdateofreceipt.2-7days,2~8°Cundersterileconditionsafterreconstitution.3-6months,-85~-65℃understerileconditionsafterreconstitution.Recombinant Human Siglec-9 Protein,His-Avi Tag糖苷內(nèi)切酶 H 是一種重組糖苷酶,能夠?qū)?N-糖蛋白中的高甘露糖和某些雜合型寡聚糖的殼二糖結(jié)構(gòu)進(jìn)行切割。

Recombinant Human LILRB2/CD85d/ILT4 Protein,His-Avi Tag,標(biāo)準(zhǔn)物質(zhì)

Angiotensin I Converting Enzyme (ACE-2), also called ACEH (ACE homologue), is a dimeric, zinc-dependent metalloprotease of the ACE family that also includes somatic and germinal ACE. ACE-2 mRNA is found at high levels in heart, testis, and kidney and at lower levels in a wide variety of tissues. ACE-2 is the SARS-CoV and SARS-CoV2 Spike protein receptor in vivo, functions catalytically as a carboxypeptidase to cleave several substrates including angiotensins I and II, and acts as a partner for B0AT1-family amino acid transporters. Through these functions, ACE-2 has been shown to be involved in several diseases including SARS, COVID19, acute lung injury, heart disease, liver and lung fibrosis, inflammatory lung disease, and cardiopulmonary disease . Full length ACE-2 protein includes an extracellular region composed of a single N-terminal peptidase domain and C-terminal collectrin-like domain (CLD), a transmembrane domain, and a short cytoplasmic tail. The N-terminal peptidase region is required for binding to SARS-CoV and SARS-CoV2 spike proteins, while the CLD contains a region that promotes dimerization and association with amino acid transporters.

N-糖苷酶F(PNGaseF)是一種酰胺水解酶,經(jīng)過(guò)和平空間站伊麗莎菌克隆,主要由腦膜炎膿桿菌等革蘭氏陰性菌分泌。酵母重組表達(dá)N-糖苷酶F(比活性:750000U/mL),可以裂解由天冬酰胺連接的高甘露糖、雜合和復(fù)雜的寡糖糖蛋白。PNGaseF的切割位點(diǎn)為糖蛋白內(nèi)側(cè)N-乙酰葡萄糖胺(GlcNAc)和天冬酰氨殘基之間的酰胺鍵,同時(shí)將酶解后蛋白上的天冬氨酰轉(zhuǎn)化為天冬氨酸。本產(chǎn)品帶his標(biāo)簽,常應(yīng)用于抗體及其相關(guān)蛋白完全去糖基化。另外,我司還提供其他類型的糖苷酶,包括酵母重組表達(dá)的N-糖苷酶F,糖苷內(nèi)切酶H,糖苷內(nèi)切酶S。產(chǎn)品信息產(chǎn)品性質(zhì)中文別名(Chinesesynonym)N-糖酰胺酶F;N-糖苷酶F英文別名(Englishsynonym)PNGaseF來(lái)源(Source)酵母重組表達(dá)分子量(Molecularweight)36kDa比活性(Specificactivity)750000U/mL緩沖液組分(Buffer)20mMTris-HClpH7.5,50mMNaCl,5mMEDTA,50%GlycerolKex2不能識(shí)別和切割單一堿性氨基酸即精氨酸或賴氨酸的羧基端肽鍵。

Recombinant Human LILRB2/CD85d/ILT4 Protein,His-Avi Tag,標(biāo)準(zhǔn)物質(zhì)

產(chǎn)品簡(jiǎn)介抑肽酶(Aprotinin),又稱為抑蛋白酶肽,是一種競(jìng)爭(zhēng)性、可逆的絲氨酸蛋白酶抑制劑,可與絲氨酸蛋白酶形成穩(wěn)定復(fù)合物并阻斷酶的活性位點(diǎn),這種結(jié)合是可逆的,大多數(shù)的抑肽酶-蛋白酶復(fù)合物在極端的pH<3.0的條件下解除結(jié)合。抑肽酶抑制糜蛋白酶、胰蛋白酶、激肽釋放酶和血纖維蛋白溶酶,不能抑制Xa因子和凝血酶。從結(jié)構(gòu)上來(lái)說(shuō),抑肽酶是一種來(lái)自牛肺的單體球狀蛋白,由58個(gè)氨基酸組成并排列在具有三個(gè)交聯(lián)二硫鍵的單個(gè)多肽鏈中。重組抑肽酶采用大腸桿菌表達(dá),在GMP法規(guī)下生產(chǎn),不含任何動(dòng)物源成分,無(wú)動(dòng)物源性的病毒污染,氨基酸序列與來(lái)源于牛肺的抑肽酶完全一致,具有與動(dòng)物源性抑肽酶相同的酶學(xué)性質(zhì),可替代動(dòng)物源性抑肽酶用于各種生物技術(shù)過(guò)程中,如:重組蛋白生產(chǎn)中抑制絲氨酸蛋白酶的活性;細(xì)胞培養(yǎng)等。另外,也提供來(lái)源于牛肺的抑肽酶(動(dòng)物源性)酶活單位:能抑制1個(gè)胰蛋白酶單位的活力稱為1個(gè)抑肽酶活力單位(EPU)。儲(chǔ)存條件凍干粉2~8℃保存,有效期2年。使用方法抑肽酶與蛋白酶是等摩爾有效結(jié)合,推薦的結(jié)合pH>6.0,在pH<3.0的條件下不結(jié)合??芍苯邮褂?.9%NaCl溶解,溶解后可-20℃儲(chǔ)存。AFGF在調(diào)節(jié)細(xì)胞存活,細(xì)胞分裂,血管生成,細(xì)胞分化和細(xì)胞遷移中起重要作用。Dermorphin

在分子生物學(xué)、生物化學(xué)或生物工程制藥研究中也常作為工具酶用于重組融合蛋白的特異性斷裂。Recombinant Human LILRB2/CD85d/ILT4 Protein,His-Avi Tag

透明質(zhì)酸酶,英文名稱Hyaluronidase,一類能夠降低體內(nèi)透明質(zhì)酸活性的酶的總稱,結(jié)構(gòu)上由4個(gè)相同亞基構(gòu)成,每個(gè)亞基分子量接近14kDa,該酶是一種糖蛋白,包含5%的甘露糖和2.2%的葡萄糖胺。功能上該酶可隨機(jī)裂解透明質(zhì)酸、軟骨素和硫酸軟骨素中的β-N-乙酰己糖胺-[1→4]糖苷鍵。常與膠原酶聯(lián)合使用于降解細(xì)胞外基質(zhì),從而從組織中分離活細(xì)胞。本品來(lái)源于牛睪丸,活力值為400–1,000units/mg,合適的pH值為4.5–6.0。產(chǎn)品性質(zhì)中文別名(ChineseSynonym)玻璃糖醛酸酶;玻璃酸酶英文別名(EnglishSynonym)Hyaluronoglucosaminidase;Hyaluronate4-glycanohydrolaseCAS號(hào)(CASNO.)37326-33-3來(lái)源(Source)牛睪丸分子量(MolecularWeight)~55kDa類型(Type)I-S外觀(Appearance)淡黃色至米黃色至褐色粉末Recombinant Human LILRB2/CD85d/ILT4 Protein,His-Avi Tag

浦斯瑞(上海)生物醫(yī)藥有限公司在同行業(yè)領(lǐng)域中,一直處在一個(gè)不斷銳意進(jìn)取,不斷制造創(chuàng)新的市場(chǎng)高度,多年以來(lái)致力于發(fā)展富有創(chuàng)新價(jià)值理念的產(chǎn)品標(biāo)準(zhǔn),在江蘇省等地區(qū)的化工中始終保持良好的商業(yè)口碑,成績(jī)讓我們喜悅,但不會(huì)讓我們止步,殘酷的市場(chǎng)磨煉了我們堅(jiān)強(qiáng)不屈的意志,和諧溫馨的工作環(huán)境,富有營(yíng)養(yǎng)的公司土壤滋養(yǎng)著我們不斷開(kāi)拓創(chuàng)新,勇于進(jìn)取的無(wú)限潛力,浦斯瑞(上海)生物醫(yī)藥供應(yīng)攜手大家一起走向共同輝煌的未來(lái),回首過(guò)去,我們不會(huì)因?yàn)槿〉昧艘稽c(diǎn)點(diǎn)成績(jī)而沾沾自喜,相反的是面對(duì)競(jìng)爭(zhēng)越來(lái)越激烈的市場(chǎng)氛圍,我們更要明確自己的不足,做好迎接新挑戰(zhàn)的準(zhǔn)備,要不畏困難,激流勇進(jìn),以一個(gè)更嶄新的精神面貌迎接大家,共同走向輝煌回來(lái)!